Thomas Brooks

Feb 7, 2024 | nature.com | Emily Nicholson |Angela Macedo Andrade |Ângela Leão Andrade |Thomas Brooks |José R. Ferrer-Paris |David Keith | +5 more

AbstractThe Kunming-Montreal Global Biodiversity Framework (GBF) of the UN Convention on Biological Diversity set the agenda for global aspirations and action to reverse biodiversity loss. The GBF includes an explicit goal for maintaining and restoring biodiversity, encompassing ecosystems, species and genetic diversity (goal A), targets for ecosystem protection and restoration and headline indicators to track progress and guide action1.

Jan 12, 2024 | nature.com | Thomas Brooks

AbstractTechnological advances enabling massively parallel measurement of biological features — such as microarrays, high-throughput sequencing and mass spectrometry — have ushered in the omics era, now in its third decade. The resulting complex landscape of analytical methods has naturally fostered the growth of an omics benchmarking industry.

Dec 5, 2023 | journals.plos.org | Ryan Huang |Wilderson Medina |Thomas Brooks |John Fitzpatrick

Loading metrics Shortly before this PLOS ONE article [1] was accepted, a similar article was published by Palacio et al. in Diversity and Distributions [2]; a preprint of the Palacio et al. article was posted on bioRxiv in May 2020 [3]. The authors did not cite [3] in [1].

Sep 12, 2023 | conbio.onlinelibrary.wiley.com | Frank Hawkins |Craig Beatty |Thomas Brooks |IUCN Gland Switzerland

Ensuring that companies can assess and manage their impacts on biodiversity will be crucial to solving the current biodiversity crisis, and regulatory and public pressure to disclose these impacts is increasing. Top-down intactness metrics (e.g. Mean Species Abundance) can be valuable for generating high-level or first-tier assessments of impact risk, but do not provide sufficient precision or guidance for companies, regulators or third-party assessors.

Aug 24, 2023 | nature.com | Thomas Brooks |Yvette I Sheline |Garret A. FitzGerald

AbstractMany chronic disease symptomatologies involve desynchronized sleep-wake cycles, indicative of disrupted biorhythms. This can be interrogated using body temperature rhythms, which have circadian as well as sleep-wake behavior/environmental evoked components. Here, we investigated the association of wrist temperature amplitudes with a future onset of disease in the UK Biobank one year after actigraphy.